Sign In
Buy DLB
$58.81
+7.03 (+13.58%)
At Close: Jul 31, 2026
Dolby Laboratories (NYSE:DLB) Receives Average Rating of “Moderate Buy” from Analysts
02:28am, Sunday, 19'th Apr 2026
Dolby Laboratories (NYSE: DLB - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the five brokerages that are covering the firm, MarketBeat Ratings reports. Two investment
Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2026 Financial Results
04:15pm, Wednesday, 08'th Apr 2026
SAN FRANCISCO, April 8, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal ye
Dolby Labs Has Easy 30% Upside
10:21am, Monday, 06'th Apr 2026
Dolby Laboratories (DLB) offers a compelling risk-reward profile with high margins, robust free cash flow, and a reasonable valuation. DLB's intrinsic value is estimated near $80 per share, implying 3
Dolby Laboratories (NYSE:DLB) Receives $90.75 Average Target Price from Analysts
01:28am, Saturday, 28'th Mar 2026
Dolby Laboratories (NYSE: DLB - Get Free Report) has been assigned an average rating of "Moderate Buy" from the five brokerages that are currently covering the company, MarketBeat reports. Two researc
Dolby Laboratories (NYSE:DLB) Reaches New 52-Week Low – What’s Next?
04:17am, Thursday, 26'th Mar 2026
Dolby Laboratories (NYSE: DLB - Get Free Report) shares reached a new 52-week low during mid-day trading on Thursday. The company traded as low as $58.13 and last traded at $58.6210, with a volume of
Dolby Named to Fast Company's Annual List of the World's Most Innovative Companies List for Fourth Time
07:00am, Tuesday, 24'th Mar 2026
Dolby Vision 2 recognized in the Consumer Electronics category as a revolutionary leap forward for picture quality SAN FRANCISCO, March 24, 2026 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB) i
New analyses show DLB patients with lower plasma pTau181 levels — indicating an earlier stage of disease and absence of Alzheimer's disease (AD) co-pathology — experienced greater clinical benefit
3 Audio Video Stocks to Buy as Industry Tailwinds Gain Momentum
01:16pm, Wednesday, 18'th Mar 2026
Investments in cutting-edge and innovative solutions are likely to aid Zacks Audio Video Production industry participants like DLB, SONO and LVO amid cautious discretionary spending.
4 Consumer Discretionary Stocks to Grab as Inflation Continues to Ease
09:41am, Wednesday, 18'th Mar 2026
ACEL, CROX, ALTO and DLB gain appeal as easing inflation boosts rate-cut hopes and earnings estimates climb for these consumer discretionary picks.
Dynamic Technology Lab Private Ltd Has $274,000 Stock Holdings in Dolby Laboratories $DLB
04:06am, Friday, 13'th Mar 2026
Dynamic Technology Lab Private Ltd reduced its position in shares of Dolby Laboratories (NYSE: DLB) by 79.5% in the undefined quarter, according to the company in its most recent Form 13F filing with
Cognition Therapeutics Advancing Zervimesine (CT1812) for Dementia with Lewy Bodies (DLB) Psychosis
07:30am, Monday, 02'nd Mar 2026
We believe regulatory strategy expedites development of potential first treatment to address DLB psychosis We believe regulatory strategy expedites development of potential first treatment to address
5 Solid Discretionary Stocks to Grab as Consumer Confidence Rebounds
10:11am, Wednesday, 25'th Feb 2026
Consumer confidence rebounds as inflation fears ease, spotlighting RSI, CROX, CALY, DLB and MCFT on upbeat earnings revisions.
Dolby Laboratories $DLB Shares Sold by Envestnet Asset Management Inc.
03:26am, Thursday, 19'th Feb 2026
Envestnet Asset Management Inc. decreased its holdings in shares of Dolby Laboratories (NYSE: DLB) by 9.9% in the undefined quarter, according to the company in its most recent Form 13F filing with th
Wall Street Analysts Predict a 40.22% Upside in Dolby Laboratories (DLB): Here's What You Should Know
10:55am, Wednesday, 18'th Feb 2026
The average of price targets set by Wall Street analysts indicates a potential upside of 40.2% in Dolby Laboratories (DLB). While the effectiveness of this highly sought-after metric is questionable,
4 Consumer Discretionary Stocks to Buy as Inflation Continues to Cool
09:36am, Wednesday, 18'th Feb 2026
Cooling inflation and rising spending lift CCL, CALY, DLB and MAR as earnings estimates climb and growth outlooks brighten.
